Eli Lilly exceeded expectations for the quarter and now projects revenue between $85-$87 billion by 2026. This increase is largely due to strong sales of Zepbound and Mounjaro.
מקור: Business News — לכתבה המלאה
לילי ה'Topping quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
כתיבת תגובה